CUI · 31980249 · J408588/2013 · MUNICIPIUL BUCUREȘTI
BIOTECHNOLOGY & NANOTECHNOLOGY R&D S.A.
Str. VASILE STROESCU, Nr. 5, Et. 1
București, MUNICIPIUL BUCUREȘTI
ANAF Live Status
Synced 17d agoInactivat: 03 Sept 2024
Source: ANAF PlatitorTvaRest v9 (public API · no auth · daily sync). Covers VAT registration, cash-basis VAT, split-payment VAT, e-Factura enrollment, and fiscal inactivity.
Revenue · 2018
1.2K RON
Net Profit · 2018
-550.8K RON
Employees · 2018
7
Equity · 2018
-2.3M RON
Registration
Tax Status
Address
București
MUNICIPIUL BUCUREȘTI
Financial Health Score
Altman Z″ inputs · 2018
- WC / TA
- -0.76
- RE / TA
- -0.35
- EBIT / TA
- 0.00
- Eq / Liab
- -0.24
How is this calculated?
We apply the Altman Z″, a bankruptcy-prediction score published by Edward Altman for private, non-manufacturing companies. It combines four ratios — each captures a different aspect of financial health — and weights them:
Z″ = 6.56·X1 + 3.26·X2 + 6.72·X3 + 1.05·X4
- X1 — Working Capital / Total Assets · short-term liquidity.
- X2 — Retained Earnings / Total Assets · cumulative profitability.
- X3 — EBIT / Total Assets · operating efficiency.
- X4 — Equity / Total Liabilities · solvency buffer.
Thresholds (Altman, 2000): Distress < 1.1, Grey 1.1–2.6, Safe > 2.6.
The 0–100 score is a linear mapping of clamped Z″ in the [0, 5] range — a visual shorthand, not an additional metric. Hover any year on the chart to see the per-year breakdown.
Caveats: Romanian bilanț doesn't split liabilities into short/long-term, so we approximate current liabilities as 0.7·I7 (SME heuristic). EBIT is approximated with I16 (gross profit), since interest is bundled into I15.
Z″ over time
Distress < 1.1 · Caution 1.1–2.6 · Safe > 2.6
Financial Performance
14 years of reporting
All figures sourced from ANAF and Ministerul Finanțelor filings. Click any data point to explore.
2011 — 2024
Net turnover (revenue) & Net Profit
Assets × Liabilities
Balance Sheet Overview
Revenues vs expenses
Total revenues vs Total expenses
Since 2016
Avg. number of employees
Year 2018
Asset Breakdown
Raw Data
Raw Financial Data
| Year | Net turnover (revenue) | Net profit | Total liabilities | Fixed assets | Current assets | Shareholders' equity | Avg. number of employees | Inventories | Receivables | Cash & bank accounts | Prepaid expenses | Deferred revenue | Provisions | Paid-in share capital | State patrimony | Total revenues | Total expenses | Gross profit | Gross loss | Net loss |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018 | 1.158 +175.7% | 0 | 9.476.900 +7.6% | 6.072.928 +0.7% | 1.132.263 +6.8% | -2.266.949 -32.1% | 7 +40.0% | 299.366 +3.5% | 825.491 +8.5% | 7.406 -25.7% | 4.760 | 0 | 0 | 267.760 +0.0% | 0 | 1.160 +92.4% | 551.993 -5.9% | 0 | 550.833 -6.0% | 550.845 -6.0% |
| 2017 | 420 | 0 | 8.805.283 +8.7% | 6.028.741 -0.2% | 1.060.438 +13.5% | -1.716.104 -51.9% | 5 +66.7% | 289.339 +76.0% | 761.138 +5.9% | 9.961 -80.3% | 0 | 0 | 0 | 267.760 +0.0% | 0 | 603 +2.6% | 586.596 +7.3% | 0 | 585.993 +7.3% | 585.993 +7.3% |
| 2016 | 0 -100.0% | 0 -100.0% | 8.102.246 +12.0% | 6.038.121 +5.4% | 934.015 +7.1% | -1.130.110 -93.5% | 3 | 164.442 +51.4% | 718.922 +12.3% | 50.651 -58.8% | 0 -100.0% | 0 | 0 | 267.760 +0.0% | 0 | 588 -99.9% | 546.553 | 0 -100.0% | 545.965 | 545.965 +10919200.0% |
| 2015 | 31.229 | 488.703 +96.1% | 7.236.556 +21.4% | 5.730.421 +14.9% | 872.083 -0.4% | -584.146 -512.0% | — | 108.618 -32.5% | 640.389 +28.3% | 123.076 -42.9% | 49.906 | — | — | 267.760 +0.0% | — | 519.932 | 0 -100.0% | 488.703 +76.2% | 0 | 5 |
| 2014 | — | 249.236 +118.7% | 5.959.369 +324.5% | 4.988.547 +4560.7% | 875.379 -35.1% | -95.443 -162.1% | 249.236 +118.7% | 160.872 -87.4% | 498.973 +993.7% | 215.534 +668.8% | — | — | — | 267.760 +0.0% | — | 0 | 28.129 -96.9% | 277.365 -73.1% | 0 | 0 |
| 2013 | — | 113.967 | 1.403.736 | 107.035 | 1.349.605 | 153.793 | 113.967 | 1.275.948 | 45.621 | 28.036 | 100.889 | — | — | 267.760 | — | 0 | 918.354 | 1.032.321 | 0 | 0 |